Analysis of Regulation of FOXP3 expression and induction of regulatory T cells for therapeutic application to autoimmune diseases.

分析 FOXP3 表达的调节和调节性 T 细胞的诱导在自身免疫性疾病治疗中的应用。

基本信息

项目摘要

Recent studies have emphasized the importance of T cells with regulatory/suppressor properties in controlling autoimmune diseases. CD4(+) CD25(+) regulatory T(T(reg)) cells play a critical role in the maintenance of peripheral tolerance and the prevention of autoimmunity. We developed anti-FOXP3 polyclonal and employed western blotting analysis and flowcytometric analysis using mononuclear cells from autoimmune diseases.1.We have explored the characteristics of CD4(+) CD25(+) T(reg) cells or FOXP3 positive cells in patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). The frequency and phenotype of CD4(+) CD25(+) T cells as well as FOXP3 positive cells in peripheral blood (PB) from patients with RA, SLE and PBMC from normal controls were analyzed. An decreased frequency of CD4+ T cells expressing CD25 or FOP3 were detected in PB from patients with RA and SLE compared with that in healthy donor.2.We transfected FOXP3 expression vectors to COST cells by lipofection and peripheral lymphocytes using nucleofector. Then expression of FOXP3 protein in both cells were confirmed by western blotting as well as by FACScan analysis.3.We also investigate the effect of cytokines or viral protein including human T lymphocytic leukemia virus tax p40 and cytomegalovirus early antigen-on expression of FOXP3 gene. We co-transfecto FOXP3 expression vector and luciferase reporter vector, which was ligated with 3 times tandem repeats of FOXP3 binding sequences to peripheral lymphocytes using nucleofector. Co-transfection of FOXP3 did not induce luciferase activities even in the presence of cytokines including IL-1,2,4,6 and TNF. Co-transfection of Tax p40 or CMV E1+2 expression vector did not increase of luciferase activities.
最近的研究强调了具有调节/抑制特性的T细胞在控制自身免疫性疾病中的重要性。CD4(+) CD25(+)调节性T(T(reg))细胞在维持外周耐受性和预防自身免疫中起关键作用。我们开发了抗foxp3多克隆,并利用自身免疫性疾病的单核细胞进行了western blotting和流式细胞术分析。我们探讨了CD4(+) CD25(+) T(reg)细胞或FOXP3阳性细胞在类风湿关节炎(RA)和系统性红斑狼疮(SLE)患者中的特征。分析了正常对照RA、SLE和PBMC患者外周血CD4(+)、CD25(+) T细胞和FOXP3阳性细胞(PB)的频率和表型。与健康供者相比,RA和SLE患者外周血中表达CD25或FOP3的CD4+ T细胞频率降低。我们将FOXP3表达载体通过脂质体转染至COST细胞,并利用核因子转染外周淋巴细胞。western blotting和FACScan分析证实两种细胞中FOXP3蛋白的表达。我们还研究了细胞因子或病毒蛋白(包括人T淋巴细胞白血病病毒税p40和巨细胞病毒早期抗原)对FOXP3基因表达的影响。我们将FOXP3表达载体与荧光素酶报告载体共转染,用核因子将FOXP3结合序列串联重复3次连接到外周淋巴细胞上。即使在IL-1、2、4、6和TNF等细胞因子存在的情况下,FOXP3的共转染也不会诱导荧光素酶的活性。共转染Tax p40或CMV E1+2表达载体均未增加荧光素酶活性。

项目成果

期刊论文数量(35)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Glucocorticoid inhibits the human pro-interleukin 1beta gene (ILIB) by decreasing DNA binding of transactivators to the signal responsiveenhancer.
糖皮质激素通过减少反式激活因子与信号反应增强子的 DNA 结合来抑制人白细胞介素 1β 基因 (ILIB)。
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Fujii;Y.et al.;Waterman WR
  • 通讯作者:
    Waterman WR
Abnormal intracellular distribution of NFAT1 in T lymphocytes from patients with systemic lupus erythematosus and characteristic clinical features
  • DOI:
    10.1016/j.clim.2006.01.001
  • 发表时间:
    2006-06-01
  • 期刊:
  • 影响因子:
    8.6
  • 作者:
    Fujii, Yuko;Fujii, Koichi;Tanaka, Yoshiya
  • 通讯作者:
    Tanaka, Yoshiya
Transcriptional regulation of multidrug resistance-1 gene by interleukin-2 in lymphocytes.
淋巴细胞中白介素2对多药耐药1基因的转录调控。
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Tsujimura;S.
  • 通讯作者:
    S.
Down-regulation of CD40 and CD80 on B cells in patients with life-threatening systemic lupus erythematosus after successful treatment with rituximab
  • DOI:
    10.1093/rheumatology/keh443
  • 发表时间:
    2005-02-01
  • 期刊:
  • 影响因子:
    5.5
  • 作者:
    Tokunaga, M;Fujii, K;Tanaka, Y
  • 通讯作者:
    Tanaka, Y
Glucocorticoid inhibits the human pro-interleukin 1β gene(ILIB) by decreasing DNA binding of transactivators to the signal-responsive enhancer.
糖皮质激素通过减少反式激活因子与信号响应增强子的 DNA 结合来抑制人白介素原 1β 基因 (ILIB)。
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kyo;F.;Futani;H.;Matsui;K.;et al.;Wayne R.Waterman.et al.
  • 通讯作者:
    Wayne R.Waterman.et al.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SAITO Kazuyoshi其他文献

SAITO Kazuyoshi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SAITO Kazuyoshi', 18)}}的其他基金

Novel strategies for treatment of rheumatic diseases by Wnt signal blockades
通过Wnt信号阻断治疗风湿性疾病的新策略
  • 批准号:
    15K09541
  • 财政年份:
    2015
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Involvement of Epithelial and endothelial to mesenchymal transition in tissue remolding of rheumatic diseases
上皮和内皮向间质转化参与风湿性疾病的组织重塑
  • 批准号:
    23591451
  • 财政年份:
    2011
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The mechanism of inflammation in autoimmune response during the acute phase of Kawasaki disease.
川崎病急性期自身免疫反应的炎症机制。
  • 批准号:
    22790969
  • 财政年份:
    2010
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
A New treatment strategy using analysis of anti-transcriptional factors antibody in connective tissue diseases.
利用结缔组织疾病抗转录因子抗体分析的新治疗策略。
  • 批准号:
    20591179
  • 财政年份:
    2008
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Therapeutic strategy for inflammatory diseases by a novel negative regulatory transcriptional factor of inflammatory cytokines
新型炎症细胞因子负调节转录因子治疗炎症性疾病的策略
  • 批准号:
    18591128
  • 财政年份:
    2006
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Treatment for rheumatoid arthritis with immunogene therapy by angiostatin
血管抑制素免疫基因疗法治疗类风湿性关节炎
  • 批准号:
    13670486
  • 财政年份:
    2001
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Crystallographic studies on inorganic components of black-and calcium bilirubinate gallstones
黑胆红素胆石和胆红酸钙胆石无机成分的晶体学研究
  • 批准号:
    08671478
  • 财政年份:
    1996
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Chemical and crystallographic characteristics and growth factors of calcium carbonate gallstones.
碳酸钙胆结石的化学和晶体学特征以及生长因子。
  • 批准号:
    02670586
  • 财政年份:
    1990
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似国自然基金

芍药苷靶向α-烯醇化酶治疗实验性自身免疫性脑脊髓炎的机制研究
  • 批准号:
    82371809
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
  • 批准号:
    31171277
  • 批准年份:
    2011
  • 资助金额:
    60.0 万元
  • 项目类别:
    面上项目
多发性硬化相关microRNA和靶基因鉴定及其对Th17和Treg细胞生成及分化的作用
  • 批准号:
    81171120
  • 批准年份:
    2011
  • 资助金额:
    57.0 万元
  • 项目类别:
    面上项目
癫痫发作机理的新探索- - - - munc 18蛋白的自身免疫作用
  • 批准号:
    30470536
  • 批准年份:
    2004
  • 资助金额:
    18.0 万元
  • 项目类别:
    面上项目
自身免疫性肝炎中新的自身抗原的鉴定、基因克隆及表达
  • 批准号:
    30080027
  • 批准年份:
    2000
  • 资助金额:
    14.0 万元
  • 项目类别:
    专项基金项目

相似海外基金

Study of Neuropilin-1 as a potential marker of self-reactive Th cells in autoimmune neuroinflammation
Neuropilin-1 作为自身免疫性神经炎症中自身反应性 Th 细胞潜在标志物的研究
  • 批准号:
    24K10278
  • 财政年份:
    2024
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Shared and distinct genetic architecture of autoimmune and hormonal alopecias
自身免疫性脱发和激素性脱发的共同和独特的遗传结构
  • 批准号:
    MR/X030466/1
  • 财政年份:
    2024
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Research Grant
Effects of maternal immune activation on autoimmune diseases in offsprings
母体免疫激活对后代自身免疫性疾病的影响
  • 批准号:
    23H02155
  • 财政年份:
    2023
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Environmental factors and risk of autoimmune rheumatic disease incidence and serology
环境因素和自身免疫性风湿病发病率和血清学的风险
  • 批准号:
    498306
  • 财政年份:
    2023
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Operating Grants
Autoantibodies and antibody-secreting cells in neurological autoimmune diseases: from biology to therapy
神经性自身免疫性疾病中的自身抗体和抗体分泌细胞:从生物学到治疗
  • 批准号:
    479128
  • 财政年份:
    2023
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Operating Grants
BIOlogic drug safety and effectiveness interNational pharmacoepidemiologIC study in pregnant women with autoimmune disorders and asthma and their children (BIONIC)
患有自身免疫性疾病和哮喘的孕妇及其子女的生物药物安全性和有效性国际药物流行病学研究(BIONIC)
  • 批准号:
    493526
  • 财政年份:
    2023
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Operating Grants
MAIT cells in lupus skin disease and photosensitivity
MAIT 细胞在狼疮皮肤病和光敏性中的作用
  • 批准号:
    10556664
  • 财政年份:
    2023
  • 资助金额:
    $ 1.92万
  • 项目类别:
Targeting the CCR6-CCL20 pathway for treatment of psoriatic joint and entheseal inflammation
靶向 CCR6-CCL20 通路治疗银屑病关节和附着点炎症
  • 批准号:
    10699251
  • 财政年份:
    2023
  • 资助金额:
    $ 1.92万
  • 项目类别:
Novel therapeutic intervention of early-stage T1D
早期 T1D 的新型治疗干预
  • 批准号:
    10698534
  • 财政年份:
    2023
  • 资助金额:
    $ 1.92万
  • 项目类别:
Immunomodulatory biomaterial to enhancing T-cell responses to triple negative breast cancer
免疫调节生物材料可增强 T 细胞对三阴性乳腺癌的反应
  • 批准号:
    10699815
  • 财政年份:
    2023
  • 资助金额:
    $ 1.92万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了